|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 17938/22957 (78%)
Visitors : 7360959
Online Users : 158
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
https://ir.csmu.edu.tw:8080/ir/handle/310902500/23409
|
Title: | Prognostic Evaluation of the Site of Invasion in Pathological Stage T3a Renal Cell Carcinoma |
Authors: | Lai, GS;Li, JR;Wang, SS;Chen, CS;Yang, CK;Hung, SC;Cheng, CL;Ou, YC;Chiu, KY |
Keywords: | Key Words;Fat invasion;pathological T3a;prognosis;renal cell carcinoma;renal vein invasion |
Date: | 2021 |
Issue Date: | 2022-08-05T09:36:49Z (UTC)
|
Publisher: | INT INST ANTICANCER RESEARCH |
ISSN: | 0258-851X |
Abstract: | Background/Aim: To investigate the prognostic values of fat invasion (FI) and renal vein invasion (RVI) in pT3a renal cell carcinoma (RCC), as single factors or concomitant presence. Patients and Methods: We retrospectively reviewed the data of 173 patients who underwent radical or partial nephrectomy for RCC in our Institution. Results: At a median follow-up time of 48 months, patients with RVI showed significantly increased risk of disease recurrence and worse cancer-specific survival (CSS) when compared to those with FI (p=0.007, p=0.022, respectively). Having combined RVI and FI did not show inferior prognosis compared to those with RVI only. In multivariable analysis, RVI was an independent factor for disease recurrence (HR=2.06, 95% CI=1.103.87, p=0.024) and CSS (HR=2.46, 95% CI=1.01-6.0, p=0.048). Conclusion: For patients with T3a renal tumors, RVI was associated with inferior prognosis compared to those with FI. |
URI: | http://dx.doi.org/10.21873/invivo.12353 https://www.webofscience.com/wos/woscc/full-record/WOS:000648906100019 https://ir.csmu.edu.tw:8080/handle/310902500/23409 |
Relation: | IN VIVO ,2021,v35,issue 2, P1083-1089 |
Appears in Collections: | [中山醫學大學研究成果] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
index.html | | 0Kb | HTML | 169 | View/Open |
|
All items in CSMUIR are protected by copyright, with all rights reserved.
|